Cargando…
Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
The brain pathology of Alzheimer’s disease (AD) is characterized by the misfolding and aggregation of both the amyloid beta (Aβ) peptide and hyperphosphorylated forms of the tau protein. Initial Aβ deposition is considered to trigger a sequence of deleterious events contributing to tau pathology, ne...
Autores principales: | Laversenne, Vanessa, Nazeeruddin, Sameer, Källstig, Emma C., Colin, Philippe, Voize, Christel, Schneider, Bernard L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681991/ https://www.ncbi.nlm.nih.gov/pubmed/33225991 http://dx.doi.org/10.1186/s40478-020-01069-3 |
Ejemplares similares
-
The neuritic plaque facilitates pathological conversion of tau in an Alzheimer's disease mouse model
por: Li, Tong, et al.
Publicado: (2016) -
Transformation of non-neuritic into neuritic plaques during AD progression drives cortical spread of tau pathology via regenerative failure
por: Tsering, Wangchen, et al.
Publicado: (2023) -
TREM2 function impedes tau seeding in neuritic plaques
por: Leyns, Cheryl E.G., et al.
Publicado: (2019) -
Amyloid-β plaque deposition measured using propagation-based X-ray phase contrast CT imaging
por: Astolfo, Alberto, et al.
Publicado: (2016) -
Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice
por: Delizannis, Argyro Thalia, et al.
Publicado: (2021)